Skip to main content
Materials Today Bio logoLink to Materials Today Bio
. 2026 Jan 24;37:102773. doi: 10.1016/j.mtbio.2026.102773

Corrigendum to “Probiotic-drug co-delivery system enhances sulfasalazine activation for inflammatory bowel disease therapy” [Mater. Today Bio, 36 (2026) 102669]

Luo Zhao a,b,1, Xinxin Liu a,b,1, Fangfang Wang a,b, Mengya Niu a,b, Zilin Ma a,b, Ziqing Wang a,b, Yange Du a,b, Shuang Gong a,b, Yuanyuan Li c, Qingling Song a,b,⁎, Yun Zhang a,b,⁎⁎, Lei Wang a,b,c,d,⁎⁎⁎
PMCID: PMC13037539  PMID: 41923981

The authors regret < In the published article, there was an error in Fig. 6E as published. The Occludin and ZO-1 immunofluorescence figures of the SSZ group were mistakenly replaced with incorrect images. The corrected figures for Fig. 6E are provided below:

Image 1

These errors did not affect the original results and conclusions of the study.>.

The authors would like to apologise for any inconvenience caused.

Contributor Information

Qingling Song, Email: songqingling@zzu.edu.cn.

Yun Zhang, Email: zhangyun@zzu.edu.cn.

Lei Wang, Email: wanglei1@zzu.edu.cn.


Articles from Materials Today Bio are provided here courtesy of Elsevier

RESOURCES